Journal of Ophthalmic & Vision Research (Jan 2018)

Evolution of cyclophotocoagulation

  • Jideofor K Ndulue,
  • Kamran Rahmatnejad,
  • Carina Sanvicente,
  • Sheryl S Wizov,
  • Marlene R Moster

DOI
https://doi.org/10.4103/jovr.jovr_190_17
Journal volume & issue
Vol. 13, no. 1
pp. 55 – 61

Abstract

Read online

Cyclodestructive techniques have been a treatment option for refractory glaucoma since its first use in the 1930s. Over the past nine decades, cyclodestruction has advanced from the initial cyclodiathermy to micropulse transscleral cyclophotocoagulation (MP-TSCPC) which is the current treatment available. Complications associated with cyclodestruction including pain, hyphema, vision loss, hypotony and phthisis have led ophthalmologists to shy away from these techniques when other glaucoma treatment options are available. Recent studies have shown encouraging clinical results with fewer complications following cyclophotocoagulation, contributing greatly to the current increase in the use of cyclophotocoagulation as primary treatment for glaucoma. We performed our literature search on Google Scholar Database, Pubmed, Web of Sciences and Cochrane Library databases published prior to September 2017 using keywords relevant to cyclodestruction, cyclophotocoagulation and treatment of refractory glaucoma.

Keywords